MagBio Gets FDA 510(k) Clearance for COVID Testing Collection Tube
MagBio Genomics, announced U.S. FDA 510(k) clearance, CE Mark approval, and global launch of its MagXtract Collection Tube.
Read MorePosted by Andy Lundin | Sep 12, 2022 | Covid 19, Needles, Tubes, and Tourniquets |
MagBio Genomics, announced U.S. FDA 510(k) clearance, CE Mark approval, and global launch of its MagXtract Collection Tube.
Read MorePosted by Andy Lundin | Sep 9, 2022 | Allergy & Autoimmune, Immunoassay |
Exosome Diagnostics presented data on their novel non-invasive saliva profiling assay for Sjögren’s Syndrome diagnosis and monitoring.
Read MorePosted by Andy Lundin | Sep 9, 2022 | Covid 19 |
An interdisciplinary team of engineers and doctors are developing new technology designed to detect severe COVID complications.
Read MorePosted by Andy Lundin | Sep 9, 2022 | Covid 19 |
A new study has elucidated novel blood markers as potential diagnostic and therapeutic targets in the treatment of Long COVID patients.
Read MorePosted by Andy Lundin | Sep 8, 2022 | Emerging & Zoonotic Diseases |
To understand how the monkeypox virus is moving through communities, researchers suggest turning to wastewater epidemiology.
Read More